Christian S Schade - Net Worth and Insider Trading
Christian S Schade Net Worth
The estimated net worth of Christian S Schade is at least $3 Million dollars as of 2024-04-19. Christian S Schade is the Chairman & CEO of Aprea Therapeutics Inc and owns about 298,616 shares of Aprea Therapeutics Inc (APRE) stock worth over $2 Million. Christian S Schade is also the Director of Integra Lifesciences Holdings Corp and owns about 32,633 shares of Integra Lifesciences Holdings Corp (IART) stock worth over $950,110. Details can be seen in Christian S Schade's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christian S Schade has not made any transactions after 2022-05-18 and currently still holds the listed stock(s).
Transaction Summary of Christian S Schade
Christian S Schade Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christian S Schade owns 4 companies in total, including Integra Lifesciences Holdings Corp (IART) , Aprea Therapeutics Inc (APRE) , and NRG Energy Inc (NRG) among others .
Click here to see the complete history of Christian S Schade’s form 4 insider trades.
Insider Ownership Summary of Christian S Schade
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IART | Integra Lifesciences Holdings Corp | 2019-05-10 | director |
| APRE | Aprea Therapeutics Inc | 2022-05-18 | director & President & CEO |
| NRG | NRG Energy Inc | 2011-01-03 | Exec VP & Chief Financial Ofc |
| OMGA | Omega Therapeutics Inc | 2023-07-10 | director |
Christian S Schade Latest Holdings Summary
Christian S Schade currently owns a total of 2 stocks. Among these stocks, Christian S Schade owns 298,616 shares of Aprea Therapeutics Inc (APRE) as of May 18, 2022, with a value of $2 Million and a weighting of 64.52%. Christian S Schade also owns 32,633 shares of Integra Lifesciences Holdings Corp (IART) as of May 10, 2019, with a value of $950,110 and a weighting of 35.48%.
Latest Holdings of Christian S Schade
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2022-05-18 | 298,616 | 5.79 | 1,727,494 |
| IART | Integra Lifesciences Holdings Corp | 2019-05-10 | 32,633 | 29.12 | 950,110 |
Holding Weightings of Christian S Schade
Christian S Schade Form 4 Trading Tracker
According to the SEC Form 4 filings, Christian S Schade has made a total of 2 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 37,500 shares on May 18, 2022, which cost Christian S Schade around $24,000.
According to the SEC Form 4 filings, Christian S Schade has made a total of 1 transactions in Integra Lifesciences Holdings Corp (IART) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Integra Lifesciences Holdings Corp is the sale of 15,658 shares on May 10, 2019, which brought Christian S Schade around $807,326.
Insider Trading History of Christian S Schade
- 1
Christian S Schade Trading Performance
GuruFocus tracks the stock performance after each of Christian S Schade's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christian S Schade is 78.8%. GuruFocus also compares Christian S Schade's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christian S Schade within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christian S Schade's insider trading performs compared to the benchmark.
Performance of Christian S Schade
Average Return
-12.56%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.7 | 78.8 | 9.98 | -12.56 | -49.47 | -67.7 |
| Relative Return to S&P 500(%) | 24.38 | 69.14 | 14.2 | -24.21 | -71.79 | -75.08 |
Christian S Schade Ownership Network
Ownership Network List of Christian S Schade
Ownership Network Relation of Christian S Schade
Christian S Schade Owned Company Details
What does Integra Lifesciences Holdings Corp do?
Who are the key executives at Integra Lifesciences Holdings Corp?
Christian S Schade is the director of Integra Lifesciences Holdings Corp. Other key executives at Integra Lifesciences Holdings Corp include Corp VP & Pres. Neurosurgery Davis Robert T. Jr. , EVP & CHRO Chantal Veillon-berteloot , and SVP & Fin & PAO Jeffrey Mosebrook .
Integra Lifesciences Holdings Corp (IART) Insider Trades Summary
Over the past 18 months, Christian S Schade made no insider transaction in Integra Lifesciences Holdings Corp (IART). Other recent insider transactions involving Integra Lifesciences Holdings Corp (IART) include a net sale of 1,456 shares made by Jeffrey Mosebrook , a net sale of 8,348 shares made by Davis Robert T. Jr. , and a net purchase of 7,792 shares made by Witte Jan De .
In summary, during the past 3 months, insiders sold 8,348 shares of Integra Lifesciences Holdings Corp (IART) in total and bought 0 shares, with a net sale of 8,348 shares. During the past 18 months, 11,647 shares of Integra Lifesciences Holdings Corp (IART) were sold and 10,432 shares were bought by its insiders, resulting in a net sale of 1,215 shares.
Integra Lifesciences Holdings Corp (IART)'s detailed insider trading history can be found in Insider Trading Tracker table.
Integra Lifesciences Holdings Corp Insider Transactions
Christian S Schade Mailing Address
Above is the net worth, insider trading, and ownership report for Christian S Schade. You might contact Christian S Schade via mailing address: Medarex, 707 State Road, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
